Merck prevails in US safety litigation over Gardasil HPV vaccine
Go back to Merck prevails in US safety litigation over Gardasil HPV vaccine| Merck & Co. (NYSE: MRK) | Delayed: 150.65 +15.48 (11.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.17 | 52 Week High | $65.46 | |||
| Open | $146.94 | 52 Week Low | $47.97 | |||
| Day High | $151.82 | P/E | 102.48 | |||
| Day Low | $144.90 | EPS | $1.47 | |||
| Volume | 10,534,758 | |||||

